| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 08/04/2004 | CN1518559A VHH single heavy chain antibody and method for its preparation in mammal |
| 08/04/2004 | CN1517436A Oxide-reductase |
| 08/04/2004 | CN1517435A Culture media for leukemia cell inducel production of dendrite cell and its culturing method and application |
| 08/04/2004 | CN1160460C Gene sequency of specific dihydro-flavono14-reducing enayme as code substrate and its use thereof |
| 08/04/2004 | CN1160453C Systems and methods for removing viral agents from blood |
| 08/04/2004 | CN1160371C NOTCH protein and their ligands |
| 08/03/2004 | US6770803 For use in food and cosmetics |
| 08/03/2004 | US6770798 Transformed plants conferring on them resistance to diseases of fungal origin |
| 08/03/2004 | US6770797 Inducing prolonged in vivo gene expression in a mammal for inhibiting alzheimer's disease associated neuronal cell death |
| 08/03/2004 | US6770749 Nucleic acids coding for both a and b chains of human p53, human leukocyte antigen(hla) restricted murine t-cell receptor (tcr); transformed cd8+ cytotoxic t lymphocytes for immunotherapy of tumors that over-express p53 |
| 08/03/2004 | US6770745 Common gamma chain blocking agents |
| 08/03/2004 | US6770743 Genetic engineered drug |
| 08/03/2004 | US6770631 Non-identical genes and their application in improved molecular adjuvants |
| 08/03/2004 | US6770480 Transferring materials into cells using porous silicon |
| 08/03/2004 | US6770478 Erythrocytic cells and method for preserving cells |
| 08/03/2004 | US6770476 Bacteria reproduced in deinococcus; endogenous plasmids |
| 08/03/2004 | US6770466 Nucleotide sequences coding enzymatic polypeptide for use in the diagnostic tool in detection, prevention and treatment of nervous system, reproductive and vascular systems disorders |
| 08/03/2004 | US6770461 High bone mass gene of 11q13.3 |
| 08/03/2004 | US6770456 Endogenous retrovirus tumor associated nucleic acids and antigens |
| 08/03/2004 | US6770449 Methods of assaying receptor activity and constructs useful in such methods |
| 08/03/2004 | US6770444 Methods of identifying or screening for agents that binds the Ob-Re |
| 08/03/2004 | US6770281 B-cell epitope peptides of HSP 65 |
| 08/03/2004 | CA2142599C Method for diagnosing and monitoring sepsis |
| 08/03/2004 | CA2089111C Smooth muscle mitogen and isolated dna coding therefor |
| 07/29/2004 | WO2004063369A1 Gene sequence of l-rhamnose isomerase having new catalytic function and use thereof |
| 07/29/2004 | WO2004063365A1 NOVEL USE OF COMPOUND HAVING TGFβ-INHIBITORY ACTIVITY |
| 07/29/2004 | WO2004063364A1 Use of retinoic esters of hyaluronic acid for the differentiation of totipotent stem cells |
| 07/29/2004 | WO2004063363A1 Different dendritic cell subsets |
| 07/29/2004 | WO2004063356A2 Persistent expression of candidate molecule in proliferating stem and progenitor cells for delivery of therapeutic products |
| 07/29/2004 | WO2004063346A2 Lysozyme transgenic ungulates |
| 07/29/2004 | WO2004063341A2 Hematopoietic stem cell niche cells |
| 07/29/2004 | WO2004063024A2 Floral packaging material having prints thereon |
| 07/29/2004 | WO2004062602A2 Compositions and methods for targeted biological delivery of molecular carriers |
| 07/29/2004 | WO2004062592A2 2-o sulfatase compositions and related methods |
| 07/29/2004 | WO2004062559A2 Use of microcapsules comprising an antigen for the manufacture of an ex-vivo medicament to initiate an immune response |
| 07/29/2004 | WO2004062554A2 Enhancement of dopaminergic neuron generation and survital |
| 07/29/2004 | WO2004062366A2 Stem-regulated, plant defense promoter and uses thereof in tissue-specific expression in monocots |
| 07/29/2004 | WO2004048408A3 Asb-a transcription repressor proteins and nucleic acids and their application in expansion of stem cells |
| 07/29/2004 | WO2004048402A3 A hepatitis c virus codon optimized non-structural ns3/4a fusion gene |
| 07/29/2004 | WO2004044156A3 Transgenic ungulates having reduced prion protein activity and uses thereof |
| 07/29/2004 | WO2004042007A3 Somatic cell gene targeting vectors and methods of use thereof |
| 07/29/2004 | WO2004041061A8 Substrates, devices, and methods for cellular assays |
| 07/29/2004 | WO2004038368A3 Device and method for monitoring leukocyte migration |
| 07/29/2004 | WO2004029069A3 Hybridomas producing high levels of human sequence antibody |
| 07/29/2004 | WO2004024746A3 Therapeutic anti-bgp(c-cam1) antibodies and uses thereof |
| 07/29/2004 | WO2004021772A8 Immune cloning and uses thereof |
| 07/29/2004 | WO2004015057A9 Mucin-immunoglobulin fusion proteins |
| 07/29/2004 | WO2004011598A3 Long lived keratinocytes |
| 07/29/2004 | WO2004004663A3 Compositions and methods for ligament growth and repair |
| 07/29/2004 | WO2003098212B1 Method of isolating an endotehelial cell and method of donor specific crossmatching |
| 07/29/2004 | WO2003097798A3 Carotene synthase gene and uses therefor |
| 07/29/2004 | WO2003093433A3 Fibrin-based biomatrix |
| 07/29/2004 | WO2003083065A3 Improved methods for achieving expression from alphavirus vectors |
| 07/29/2004 | WO2003080806A3 Method for production of neutrophils and uses therefor |
| 07/29/2004 | WO2003078599A3 Method for generating primate trophoblasts |
| 07/29/2004 | WO2003078598A3 Methods for using bag expression as a cell differentiation agent and marker |
| 07/29/2004 | WO2003068915A3 Production of human antibodies in immunodeficient, non-human, mammalian hosts |
| 07/29/2004 | WO2003068803A3 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof |
| 07/29/2004 | WO2003059951A8 Novel anti-igf-ir antibodies and uses thereof |
| 07/29/2004 | WO2003054177A3 New glycosyl hydrolases |
| 07/29/2004 | WO2003027256A3 Methods and compositions for monitoring cell migration and identifying clinically relevant cytotoxic t lymphocyte activity |
| 07/29/2004 | WO2003025150A3 Lipid-associated molecules |
| 07/29/2004 | WO2003022123A3 Methods of kidney transplantation utilizing developing nephric tissue |
| 07/29/2004 | WO2003011209A3 Methods of sensitizing hepatocyte cell cultures to hepatitis infection, beads coated with hbv or hcv polypeptides and methods of using such beads to model viral infection or deliver substances into hepatocytes |
| 07/29/2004 | WO2002094994A3 Chimeric antigen-specific t cell-activating polypeptides |
| 07/29/2004 | WO2002067957A8 Use of defibrinated blood for manufacture of a hemoglobin-based oxygen carrier |
| 07/29/2004 | US20040148649 for plants cells, tissue or entire plants (maize, tobacco, alfalfa, rice, soybean, pea, wheat, barley, sunflower, potato, tomato, and cotton) which comprise a coding region for herbicide/insect/drought/cold resistance |
| 07/29/2004 | US20040148645 ATP diphosphohydrolase (CD39) gene therapy for inflammatory or thrombotic conditions and transplantation and means therefor |
| 07/29/2004 | US20040148643 by incubating a first parental cell producing a first partner of a fusogenic binding partner pair on its surface with a second parental cell producing a second partner of the fusogenic binding partner pair; for producing monclonal antibodies; kits |
| 07/29/2004 | US20040147733 for diagnosis/therapy for immune system-related disorders; drug screening; genetic engineering |
| 07/29/2004 | US20040147725 for cancer treatment by inducing apoptosis; monoclonal antibodies; genetic engineering; kits |
| 07/29/2004 | US20040147724 for diagnosis/treatment of cancer, myeloproliferative disorders, angiogenesis, obesity, osteoporosis, non-insulin dependent diabetes, lipid metabolism disorder, hypercalcemia, hypercholestrolemia; genetic engineering |
| 07/29/2004 | US20040147472 Antisense modulation of transforming growth factor beta receptor II expression |
| 07/29/2004 | US20040147465 Treatment for wounds |
| 07/29/2004 | US20040147450 To promote bone growth in mammals |
| 07/29/2004 | US20040147437 Calycins |
| 07/29/2004 | US20040147024 comprising loading a biological sample with a solute by fluid phase endocytosis to produce an internally loaded dehydrated biological sample; for hemostasis aid that can be rehydrated just before the time of application |
| 07/29/2004 | US20040147021 able to exert contact-independent regulatory functions; comprises stimulating the T cells with stimulating agent or antigen presenting cells ex/in vivo; injectible drugs |
| 07/29/2004 | US20040147020 for alleviating Parkinson's disease symptoms by administering cultured cells comprising tyrosine hydroxylase-positive neurons to the putamen of patient |
| 07/29/2004 | US20040147019 comprises a mixture of mature neuronal retinal cells and cells isolated from a ciliary body; for drug screening neurodegeneration inhibitors |
| 07/29/2004 | US20040147018 tissue engineering; for heart/gastrointestinal system implant and a substitute for connective, lung, trachea, bronchia, cartilage, skin, muscle, and bone tissue |
| 07/29/2004 | US20040147017 for pharmaceuticals, diagnostics, biosensors and bioreactors; thrombolytic agents, interferons, interleukins, erythropoietins, colony stimulating factors, and cytokines; solid phase synthesis |
| 07/29/2004 | US20040147016 Programmable scaffold and methods for making and using the same |
| 07/29/2004 | US20040147015 Culturing tissue using magnetically generated mechanical stresses |
| 07/29/2004 | US20040147004 Comprises nucleotide sequences coding enzymatic polypeptide for use as tool in identifying modulators for diagnosis, treatment and prevention of cancer and cell proliferative disorders |
| 07/29/2004 | US20040147003 Comprises nucleotide sequences coding kinase for use as tool in identifying modulators for treatment and prevention cell proliferative disorders |
| 07/29/2004 | US20040146990 Compositions and methods for generating monoclonal antibodies representative of a specific cell type |
| 07/29/2004 | US20040146988 Interferon-like protein zcyto21 |
| 07/29/2004 | US20040146987 Nucleotide sequences coding chloramphenicol acetyltransferase, luciferase, beta-glucuronidase or beta-galactosidase gnetically engineered fusion polypeptide with reduced half-life of expression; diagnostic tools for genetic and disease analysis |
| 07/29/2004 | US20040146986 Nucleotide sequences coding transcription factor associated with tumor suppressor activity for use in treatment and prevention of cell proliferative disorders |
| 07/29/2004 | US20040146981 DNA encoding human serine protease D-G |
| 07/29/2004 | US20040146972 Humanized polynucleotide sequence encoding renilla mulleri green fluorescent protein |
| 07/29/2004 | US20040146952 T cell receptors mutants that have higher affinity for the peptide/MHC ligand than the wild type; can be used in place of an antibody or single chain antibody |
| 07/29/2004 | US20040146948 single-chain variable region fragment (scFv) comprising a heavy chain variable region (VH) operably linked to a light chain variable region (VL); for cancer treatment |
| 07/29/2004 | US20040146940 Cripto blocking antibodies and uses thereof |
| 07/29/2004 | US20040146933 Latent human tuberculosis model, diagnostic antigens, and methods of use |
| 07/29/2004 | US20040146930 for diagnosing susceptibility to a pathological condition based on the presence or absence of mutation; drug screening; genetic engineering |
| 07/29/2004 | US20040146929 for drug screening, in vitro or in vivo diagnosis, and gene therapy; antitumor agents; genetic engineering; kits |
| 07/29/2004 | US20040146923 for treatment of tendinitis and tendon or ligament defects and in related tissue repair, wound healing, and augmenting bone morphogenetic protein (bmp) activity |
| 07/29/2004 | US20040146908 Fibroblast growth factor-19 (FGF-19) nucleic acids and polypeptides and methods of use for the treatment of obesity and related disorders |